Literature DB >> 6668549

A time-dependent volume of distribution term used to describe linear concentration-time profiles.

W A Colburn.   

Abstract

The present study was conducted to develop, test, and apply a single exponential time-dependent volume of distribution function to describe the pharmacokinetics of compounds following instantaneous, zero-order and first order input. Simulations were used to show the applicability and flexibility of the equations. Experimental data from the literature were fitted using the equations developed in the present study. In addition, the results of these fitted curves were compared to the results of the original fitting procedures to compare and contrast the methods. In the present analysis, the change from an initial volume (V1) to the total volume (V T) is perceived as a simple exponential function. Therefore, a single exponential term to describe elimination and a single exponential term to describe the change from V1 to V T were used to describe the entire blood concentration profile. The results from present simulations and fitted data indicate that the transition from V1 to V T is a more continuous process than observed with classical methods and is consistent with results obtained from physiologic flow-limited models. This observation suggests that the present curve-fitting technique may be more akin to physiologic reality, in that it depicts the change from the initial volume of distribution to the total volume of distribution as a continuous exponential function which reflects the establishment of an equilibrium.

Mesh:

Substances:

Year:  1983        PMID: 6668549     DOI: 10.1007/bf01058957

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  10 in total

1.  Volume of distribution as a function of time.

Authors:  S Niazi
Journal:  J Pharm Sci       Date:  1976-03       Impact factor: 3.534

2.  Pharmacokinetics of flunitrazepam following single- and multiple-dose oral administration to healthy human subjects.

Authors:  H G Boxenbaum; H N Posmanter; T Macasieb; K A Geitner; R E Weinfeld; J D Moore; A Darragh; D A O'Kelly; L Weissman; S A Kaplan
Journal:  J Pharmacokinet Biopharm       Date:  1978-08

3.  Pharmacokinetic model for serum concentrations of ampicillin in the newborn infant.

Authors:  W A Colburn; M Gilbaldi; H Yoshioka; M Takimoto; H D Riley
Journal:  J Infect Dis       Date:  1976-07       Impact factor: 5.226

4.  Statistical estimations in pharmacokinetics.

Authors:  H G Boxenbaum; S Riegelman; R M Elashoff
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

5.  Stability of heparin and other fractions of glycosaminoglycan sulfates in human digestive juices.

Authors:  S Oie; T W Guentert
Journal:  J Pharm Sci       Date:  1982-01       Impact factor: 3.534

6.  Pharmacokinetics of ampicillin in the newborn infant.

Authors:  H Yoshioka; M Takimoto; H D Riley
Journal:  J Infect Dis       Date:  1974-04       Impact factor: 5.226

7.  A model independent approach to describe the blood disappearance profile of intravenously administered drugs.

Authors:  K Takada; S Asada
Journal:  Chem Pharm Bull (Tokyo)       Date:  1981-05       Impact factor: 1.645

8.  First-pass clearance of lidocaine in healthy volunteers and epileptic patients: influence of effective liver volume.

Authors:  W A Colburn
Journal:  J Pharm Sci       Date:  1981-08       Impact factor: 3.534

9.  Comparative pharmacokinetics of coumarin anticoagulants XLIV: Dose-dependent pharmacokinetics of warfarin in rats.

Authors:  K Takada; G Levy
Journal:  J Pharm Sci       Date:  1980-01       Impact factor: 3.534

10.  Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients.

Authors:  E Perucca; A Richens
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

  10 in total
  4 in total

1.  Validation of a decision support system for use in drug development: pharmacokinetic data.

Authors:  S Guzy; C A Hunt
Journal:  Pharm Res       Date:  1997-10       Impact factor: 4.200

2.  Generalizations in linear pharmacokinetics using properties of certain classes of residence time distributions. I. Log-convex drug disposition curves.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1986-12

3.  Time Varying Apparent Volume of Distribution and Drug Half-Lives Following Intravenous Bolus Injections.

Authors:  Carl A Wesolowski; Michal J Wesolowski; Paul S Babyn; Surajith N Wanasundara
Journal:  PLoS One       Date:  2016-07-12       Impact factor: 3.240

4.  Scientific Rationale for Waiving Clinical Efficacy Testing of Biosimilars.

Authors:  Sarfaraz Niazi
Journal:  Drug Des Devel Ther       Date:  2022-08-24       Impact factor: 4.319

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.